US Cites PhRMA’s Drug Price Suit Loss as Defense in Chamber Case

The recent dismissal of a key pharmaceutical industry group’s drug pricing lawsuit was used as an argument in the latest turn in the legal battle between the Biden administration and the US Chamber of Commerce.

The US Department of Justice’s response Wednesday to the US Chamber and affiliates in a case debating a federal price-setting program points to the government’s victory against the Pharmaceutical Research and Manufacturers of America when a judge tossed the case due to lack of jurisdiction.

The US District Court for the Western District of Texas ruled Feb. 12 it lacks jurisdiction to handle PhRMA’s case, ...